27
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction

Pages 297-304 | Published online: 12 Jul 2009
 

Abstract

Objective : YKL-40 is a secretory glycoprotein of chondrocytes, synovial cells, macrophages, and neutrophils. The aims were to determine serum YKL-40 in patients with early rheumatoid arthritis (RA) and seek associations with early joint erosions. Methods : YKL-40 was measured by ELISA in serum samples collected every three month for 36 months from patients with early RA. The patients were treated with DMARDs and some were allocated to additional prednisolone. Results : Serum YKL-40 was higher in RA patients compared with controls (98 vs. 42 &#119 g/l, p < 0.001). The mean serum YKL-40 during the study correlated with the progression in Larsen score (Pearson's test: p = 0.004). Patients with a persistently high serum YKL-40 had larger progression in Larsen score compared with patients with normal serum YKL-40 (median progression: 7 vs. 0, p = 0.003). Conclusion : These data suggest that elevated serum YKL-40 is related to progression in joint destruction in early RA patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.